At the end of the latest market close, Athenex Inc. (ATNX) was valued at $1.23. In that particular session, Stock kicked-off at the price of $1.30 while reaching the peak value of $1.3049 and lowest value recorded on the day was $1.14. The stock current value is $1.14.Recently in News on January 12, 2022, Athenex Announces Agreement with ImmunityBio Regarding Dunkirk Manufacturing Facility. Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today that it has entered into a definitive agreement for ImmunityBio, Inc. (NASDAQ: IBRX) to assume its leasehold interest in a manufacturing facility in Dunkirk, New York, and certain related assets for approximately $38 million, subject to adjustment at closing. Proceeds from the sale will be used to service the Company’s debt obligations and for other general corporate purposes. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2022. You can read further details here
Athenex Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.6600 on 01/04/22, with the lowest value was $1.1400 for the same time period, recorded on 01/12/22.
Athenex Inc. (ATNX) full year performance was -89.33%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Athenex Inc. shares are logging -92.40% during the 52-week period from high price, and -5.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.20 and $15.00.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1604958 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Athenex Inc. (ATNX) recorded performance in the market was -16.18%, having the revenues showcasing -57.93% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 129.53M, as it employees total of 593 workers.
The Analysts eye on Athenex Inc. (ATNX)
During the last month, 0 analysts gave the Athenex Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.4172, with a change in the price was noted -2.15. In a similar fashion, Athenex Inc. posted a movement of -65.35% for the period of last 100 days, recording 1,178,403 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ATNX is recording 0.99 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.94.
Technical rundown of Athenex Inc. (ATNX)
Raw Stochastic average of Athenex Inc. in the period of last 50 days is set at 0.00%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 0.00%. In the last 20 days, the company’s Stochastic %K was 6.70% and its Stochastic %D was recorded 6.24%.
Considering, the past performance of Athenex Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -16.18%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -71.28%, alongside a downfall of -89.33% for the period of the last 12 months. The shares increased approximately by -16.18% in the 7-day charts and went up by -23.49% in the period of the last 30 days. Common stock shares were lifted by -57.93% during last recorded quarter.